Key Highlights

  • Jatcorp (ASX:JAT) traded at $0.075, down 11.77%, after touching a 52-week low during the 26 October 2026 session.
  • FY26 Revenue rose 23% to $38.9 million, while Gross Profit Margin fell to 15.81% from 19.77%.
  • Statutory loss after tax improved to $4.7 million from $6.9 million, and Operating Cash Flow was an outflow of $1.4 million.

Jatcorp Limited (ASX:JAT) shares touched a 52-week low during the Trading session on 26 October 2026, trading at $0.075, down 11.77% on the day. Jatcorp develops, manufactures and markets nutritional and dairy-based consumer products, including the Moroka and Neurio brands, from a Melbourne Manufacturing facility. Its Annual Report for the year ended 30 June 2026 was authorised for issue on 21 September 2026.

FY26 Results Published in September

The annual report shows total revenue from operations of $38.9 million, up 23% from $31.6 million. Gross profit was $6.1 million, broadly in line with the prior year's $6.2 million, so gross margin fell from 19.77% to 15.81%. The statutory loss after tax improved to $4.7 million from $6.9 million, and EBITDA improved to a loss of $3.4 million from a loss of $5.9 million.

After adjusting for Impairment losses and inventory write-downs, adjusted EBITDA was a loss of $2.7 million, compared with a loss of $1.8 million in FY25, which moved in the opposite direction to the reported EBITDA figure. Net cash used in Operating Activities was $1.4 million, compared with a $1.6 million inflow in FY25.

The report states that revenue growth reflected increased activity across key brands and channels, and that lower gross margin and operating cash outflow demonstrate that improving margin quality, working-capital discipline and operating efficiency remain priorities for FY27. The EBITDA improvement and the widening of adjusted EBITDA loss reflect the effect of impairment losses and inventory write-downs, which are adjusted out of the latter measure.

Brands, Channels and Manufacturing

Jatcorp's principal activities cover product development and commercialisation, Brand and channel development, distribution across Australia, China and selected Southeast Asian markets, and contract manufacturing for third-party customers through its Melbourne-based ANMA facility. Sales commenced in Vietnam during the year, and the company is preparing the iOne Milk range for launch.

Its formulations target all age groups, from infants to seniors, and frequently incorporate lactoferrin and other natural ingredients. The chair's letter describes FY26 as a year of transition after a challenging FY25, with the group returning to revenue growth while continuing to invest in distribution, product development and manufacturing capability.

Lactoferrin is a protein found in milk, and the company says its products frequently use it with other natural ingredients intended to support immune function and intestinal health. Contract manufacturing for third-party customers through ANMA, the Melbourne-based facility, is a separate revenue line from the company's own brands.

About Jatcorp

Jatcorp's brand portfolio includes Moroka and Neurio, with iOne Milk in preparation, and its OEM manufacturing activity through ANMA supplies third-party customers. The company states its priorities for FY27 as margin quality, working-capital discipline and operating efficiency.

Risks

The chair's letter acknowledges a challenging operating environment and lists commercial and operational risks including intellectual property matters, customer and market concentration, working Capital and funding requirements. Gross margin declined year on year, and operating cash flow turned from an inflow to an outflow. The company said the board is maintaining close focus on cash flow, expenditure and commercial commitments.

The directors' report states that gross profit was broadly in line with the prior year, which means the 23% revenue increase did not translate into higher gross profit dollars. Operating cash flow moved from a $1.6 million inflow in FY25 to a $1.4 million outflow in FY26, and the report lists Working Capital and funding requirements among the matters the board is monitoring.

Catalysts on Investors' Radar

Items the company has pointed to include the launch of the iOne Milk range, expanded distribution in Australia, China and Southeast Asia, growth in OEM manufacturing through ANMA and further sales development in Vietnam. Its next periodic reports will show how revenue and margins progress.

The company's key brands, Moroka and Neurio, sit alongside contract manufacturing for third parties, and the board has said it will pursue opportunities selectively having regard to available resources. The report names margin quality, working-capital discipline and operating efficiency as the priorities for FY27.

Final Perspective

Jatcorp touched a 52-week low on a day when the company's most recent filing was its annual report. Its FY26 report combines higher revenue and a smaller statutory loss with a lower gross margin and an operating cash outflow.